Search

Padmavathi Baskar

Examiner (ID: 13817, Phone: (571)272-0853 , Office: P/1645 )

Most Active Art Unit
1645
Art Unit(s)
1641, 1645
Total Applications
1590
Issued Applications
1047
Pending Applications
159
Abandoned Applications
391

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 11547292 [patent_doc_number] => 09616114 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2017-04-11 [patent_title] => 'Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity' [patent_app_type] => utility [patent_app_number] => 14/858810 [patent_app_country] => US [patent_app_date] => 2015-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 11 [patent_no_of_words] => 20571 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 183 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14858810 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/858810
Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity Sep 17, 2015 Issued
Array ( [id] => 10727491 [patent_doc_number] => 20160073640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-17 [patent_title] => 'COMPOSITIONS COMPRISING RECOMBINANT BACILLUS CELLS AND ANOTHER BIOLOGICAL CONTROL AGENT' [patent_app_type] => utility [patent_app_number] => 14/857176 [patent_app_country] => US [patent_app_date] => 2015-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 32551 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14857176 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/857176
Compositions comprising recombinant Sep 16, 2015 Issued
Array ( [id] => 11684079 [patent_doc_number] => 09682110 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-06-20 [patent_title] => 'Antibacterial phage, phage peptides and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 14/852112 [patent_app_country] => US [patent_app_date] => 2015-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 228 [patent_figures_cnt] => 230 [patent_no_of_words] => 24966 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14852112 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/852112
Antibacterial phage, phage peptides and methods of use thereof Sep 10, 2015 Issued
Array ( [id] => 14653555 [patent_doc_number] => 20190233906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-01 [patent_title] => MUTANT STRAINS OF STAPHYLOCOCCUS AUREUS WITH MULTIPLE INACTIVATED TCS SYSTEMS [patent_app_type] => utility [patent_app_number] => 15/755531 [patent_app_country] => US [patent_app_date] => 2015-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25699 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15755531 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/755531
MUTANT STRAINS OF STAPHYLOCOCCUS AUREUS WITH MULTIPLE INACTIVATED TCS SYSTEMS Aug 25, 2015 Abandoned
Array ( [id] => 11297815 [patent_doc_number] => 09505810 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-29 [patent_title] => 'Toxins in type A Clostridium perfringens' [patent_app_type] => utility [patent_app_number] => 14/832647 [patent_app_country] => US [patent_app_date] => 2015-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 7 [patent_no_of_words] => 23945 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14832647 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/832647
Toxins in type A Clostridium perfringens Aug 20, 2015 Issued
Array ( [id] => 10812177 [patent_doc_number] => 20160158337 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-09 [patent_title] => 'CHLAMYDIA ANTIGENS' [patent_app_type] => utility [patent_app_number] => 14/831535 [patent_app_country] => US [patent_app_date] => 2015-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 35769 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14831535 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/831535
Chlamydia antigens Aug 19, 2015 Issued
Array ( [id] => 10670876 [patent_doc_number] => 20160017022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-21 [patent_title] => 'Methods to Protect Against and Treat Multiple Sclerosis' [patent_app_type] => utility [patent_app_number] => 14/826476 [patent_app_country] => US [patent_app_date] => 2015-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 29069 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14826476 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/826476
Methods to protect against and treat multiple sclerosis Aug 13, 2015 Issued
Array ( [id] => 10728343 [patent_doc_number] => 20160074492 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-17 [patent_title] => 'Oral Vaccine For Borrelia' [patent_app_type] => utility [patent_app_number] => 14/819984 [patent_app_country] => US [patent_app_date] => 2015-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 22212 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14819984 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/819984
Oral Vaccine For Borrelia Aug 5, 2015 Abandoned
Array ( [id] => 14168125 [patent_doc_number] => 10258048 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-04-16 [patent_title] => None [patent_app_type] => utility [patent_app_number] => 14/814122 [patent_app_country] => US [patent_app_date] => 2015-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 17 [patent_no_of_words] => 14068 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14814122 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/814122
None Jul 29, 2015 Issued
Array ( [id] => 11210917 [patent_doc_number] => 09439934 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2016-09-13 [patent_title] => 'Application of an attenuated salmonella typhimurium, its genetically engineered bacterium in preparing drugs for the treatment of prostate cancer' [patent_app_type] => utility [patent_app_number] => 14/813338 [patent_app_country] => US [patent_app_date] => 2015-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 3467 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14813338 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/813338
Application of an attenuated salmonella typhimurium, its genetically engineered bacterium in preparing drugs for the treatment of prostate cancer Jul 29, 2015 Issued
Array ( [id] => 11357379 [patent_doc_number] => 09534022 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-03 [patent_title] => 'Proteins and nucleic acids useful in vaccines targeting Staphylococcus aureus ' [patent_app_type] => utility [patent_app_number] => 14/802602 [patent_app_country] => US [patent_app_date] => 2015-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22308 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14802602 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/802602
Proteins and nucleic acids useful in vaccines targeting Staphylococcus aureus Jul 16, 2015 Issued
Array ( [id] => 11773465 [patent_doc_number] => 09382302 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-07-05 [patent_title] => 'Lutzomyia longipalpis polypeptides and methods of use' [patent_app_type] => utility [patent_app_number] => 14/802168 [patent_app_country] => US [patent_app_date] => 2015-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 7 [patent_no_of_words] => 28805 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14802168 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/802168
Lutzomyia longipalpis polypeptides and methods of use Jul 16, 2015 Issued
Array ( [id] => 11224502 [patent_doc_number] => 09452213 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-09-27 [patent_title] => 'Genetically detoxified pertussis vaccine that maintains intrinsic adjuvant activity' [patent_app_type] => utility [patent_app_number] => 14/800126 [patent_app_country] => US [patent_app_date] => 2015-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2779 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14800126 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/800126
Genetically detoxified pertussis vaccine that maintains intrinsic adjuvant activity Jul 14, 2015 Issued
Array ( [id] => 12930910 [patent_doc_number] => 09829490 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-11-28 [patent_title] => Use of amino acid sequences from [patent_app_type] => utility [patent_app_number] => 14/798241 [patent_app_country] => US [patent_app_date] => 2015-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 9727 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 158 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14798241 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/798241
Use of amino acid sequences from Jul 12, 2015 Issued
Array ( [id] => 10483288 [patent_doc_number] => 20150368304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-24 [patent_title] => 'NUCLEIC ACIDS AND PROTEINS FROM STREPTOCOCCUS GROUPS A AND B' [patent_app_type] => utility [patent_app_number] => 14/751790 [patent_app_country] => US [patent_app_date] => 2015-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 95 [patent_figures_cnt] => 95 [patent_no_of_words] => 47729 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14751790 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/751790
Nucleic acids and proteins from Streptococcus groups A and B Jun 25, 2015 Issued
Array ( [id] => 10389806 [patent_doc_number] => 20150274814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-01 [patent_title] => 'METHODS OF TREATING AND PREVENTING STAPHYLOCOCCUS AUREUS INFECTIONS AND ASSOCIATED CONDITIONS' [patent_app_type] => utility [patent_app_number] => 14/736751 [patent_app_country] => US [patent_app_date] => 2015-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14569 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14736751 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/736751
Methods of treating and preventing Staphylococcus aureus infections and associated conditions Jun 10, 2015 Issued
Array ( [id] => 15338871 [patent_doc_number] => 10525092 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-01-07 [patent_title] => Compositions and methods for preventing infections [patent_app_type] => utility [patent_app_number] => 15/317603 [patent_app_country] => US [patent_app_date] => 2015-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3036 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 182 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15317603 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/317603
Compositions and methods for preventing infections Jun 10, 2015 Issued
Array ( [id] => 11184780 [patent_doc_number] => 09416172 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-16 [patent_title] => 'Compositions and methods for treating and preventing Staphylococcus aureus infections' [patent_app_type] => utility [patent_app_number] => 14/729260 [patent_app_country] => US [patent_app_date] => 2015-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 11969 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14729260 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/729260
Compositions and methods for treating and preventing Staphylococcus aureus infections Jun 2, 2015 Issued
Array ( [id] => 10365837 [patent_doc_number] => 20150250842 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-10 [patent_title] => 'COMBINATION AND/OR COMPOSITION COMPRISING BACILLUS, AND YUCCA, QUILLAJA, OR BOTH AND A METHOD FOR USING AND MAKING' [patent_app_type] => utility [patent_app_number] => 14/699740 [patent_app_country] => US [patent_app_date] => 2015-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 9594 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14699740 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/699740
Combination and/or composition comprising bacillus, and yucca, quillaja, or both and a method for using and making Apr 28, 2015 Issued
Array ( [id] => 11342388 [patent_doc_number] => 09526774 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2016-12-27 [patent_title] => 'Methods and compositions for suppressing virulence of methicillin resistant Staphylococcus aureus ' [patent_app_type] => utility [patent_app_number] => 14/690889 [patent_app_country] => US [patent_app_date] => 2015-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7764 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14690889 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/690889
Methods and compositions for suppressing virulence of methicillin resistant Staphylococcus aureus Apr 19, 2015 Issued
Menu